Online event: Investing in Precision Medicine

Dear Josb,

Investing in Precision Medicine
Tech-powered personalized treatments

Monday, March 28th, 2022

6PM Israel | 11AM New York | 8AM San Francisco
7PM Abu Dhabi | 4PM London | 8:30PM Mumbai

Join a virtual event with

Prof. Aaron Ciechanover – Nobel Laureate and Scientific Advisor to OncoHost
David (Dudi) Baum– Co-Founder & CEO, Genopore
Ophir Herbst – Co-Founder & CEO, Sequentify
Dr. Ofer Sharon – CEO, OncoHost
Dr. Liran Shlush – Senior Scientist, Weizmann Institute, Sequentify Medical Advisor
Host: Jon Medved, Founder & CEO, OurCrowd

The power of advanced medical technology is coming to a doctor's office near you. Instead of prescribing drugs or treatments which are one size fits all, artificial intelligence and other technologies allow doctors to use therapies tailor made for an individual patient.

Join us on March 28th to take a look under the digital microscope at cost-effective DNA testing, protein identification, advanced disease screening and more with the CEOs and top advisors of Genopore, OncoHost and Sequentify, cutting-edge MedTech companies now funding on the OurCrowd platform.

Click here or the button below to register.

Can't make it? Register and we'll send you the recording.

Nothing contained in and accompanying this communication shall be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security by OurCrowd, its portfolio companies or any third party. Information regarding OurCrowd's limited partnerships and/or portfolio companies and the investment opportunities on OurCrowd's website is intended and available for accredited investors only (criteria at OurCrowd). OurCrowd urges potential investors to consult with licensed legal professionals and investment advisors for any legal, tax, insurance, or investment advice.OurCrowd operates in Canada through OurCrowd Canada Inc., an exempt market dealer registered in the Provinces of British Columbia, Alberta, Manitoba, Ontario, Quebec and Nova Scotia.